However, as we demonstrated that PDGFRA inhibition is sufficient to abrogate the effect of Endocan on GBM cells, we can speculate that, at least in our experimental model, PDGFRA is the main receptor for Endocan. The gene discussed is ESM1; the disease is glioblastoma.